Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer
Authors:
Open Access
- 7 December 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 41 (2) , 875-884
Abstract
Researchers hold the view that PLAGL2 is overexpressed in many malignancies and that it can promote tumor proliferation, migration, invasion and self‑renewal; however, there is no evidence revealing a relationship between PLAGL2 and colorectal cancer (CRC). In the present study, genes that are overexpressed in CRC were screened using the COSMIC database and GEPIA database and the expression of PLAGL2 in carcinoma tissues and pericarcinomatous tissues was detected by RT‑qPCR and western blot assays. A Cell Counting Kit‑8 assay, a cell cycle analysis experiment and a xenograft model were used to explore the influence of PLAGL2 on CRC after knocking down PLAGL2 expression in HCT116 and SW480 cells. Using ChIP assays and Dual‑Luciferase Reporter assays, the promoter regions to which PLAGL2 binds were discovered. It was observed that PLAGL2 was overexpressed in colorectal cancer and that it influenced the colorectal cancer cell cycle and promoted colorectal cancer proliferation in vivo and in vitro. The expression of some genes in the Wnt/β‑catenin pathway, were downregulated after knocking down the expression of PLAGL2; Wnt6 was altered the most. PLAGL2 could bind to the promoter region of Wnt6 and promote its expression. These results indicated that PLAGL2 was overexpressed in CRC as a proto‑oncogene and that it could active the Wnt/β‑catenin pathway as a transcription factor by binding with the promoter region of Wnt6. PALGL2 was revealed to play an important role in colorectal cancer and may be a new therapeutic target for targeted medicine.Keywords
This publication has 35 references indexed in Scilit:
- Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysemaLung Cancer, 2011
- PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and GliomasCancer Cell, 2010
- Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complexGene, 2009
- Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylationBiochemical and Biophysical Research Communications, 2008
- Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylationJournal of Biological Chemistry, 2004
- β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinBCell, 2002
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- DNA Recognition by Cys2His2 Zinc Finger ProteinsAnnual Review of Biophysics, 2000
- Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocationsNature Genetics, 1997